SkinSight(TM) AI by ModuleMD: Smarter Skin Analysis, Faster Clinical Decisions
Thursday, January 22, 2026
GRAND BLANC, Mich., Dec. 10, 2025 /PRNewswire/ -- ModuleMD, ranked as one of America's fastest-growing companies on the Inc. 5000 and top-rated EHR vendor on G2, announces SkinSight(TM) AI, a solution that brings automation, accuracy, and consistency to one of the most manual and variable workflows in allergy care: skin test measurement and documentation.
https://mma.prnewswire.com/media/2637848/Module_MD_Logo.jpg
For years, allergy practices have been expected to deliver better documentation, clearer outcomes, and stronger patient communication while reimbursement remains unchanged.
SkinSight(TM) AI introduces a new era of standardization that meets these growing operational demands without adding work, steps, or hardware.
Why SkinSight(TM) AI Matters Today
Allergy skin testing remains highly subjective, often relying on staff experience, manual measurement, and individual interpretation. SkinSight(TM) AI removes these inconsistencies and replaces them with an objective, data-driven process designed for accuracy, efficiency, and trust.
SkinSight(TM) AI delivers:
1. More objective and consistent measurementsStandardizes grading across
staff, days, and clinic locations, reducing human variability and
ensuring every reaction is evaluated the same way.
2. Increased accuracy in identifying wheal and flare boundariesPrecisely
detects subtle and irregular reactions that are difficult for the human
eye to measure.
3. Saves time during the patient visitAutomates measurement and grading in
seconds, freeing up several minutes per test without changing workflow.
4. Automatically documents results to the patient recordStructured,
time-stamped measurements and images flow directly into the EHR,
eliminating manual entry and reducing errors.
5. Supports research and outcomes analysisAggregates usable data for trend
studies, protocol refinement, and practice-driven clinical research.
6. Builds patient trust in test resultsTransparent measurements and visuals
make results easier for patients to understand and increase confidence in
the care they receive.
7. Enables review of test results laterImproves follow-up conversations by
allowing clinicians to revisit past results with clarity and precision.
8. Allows visual timeline comparisonsTracks reaction progression over time
to support treatment decisions, therapy adjustments, and patient
education.
How SkinSight(TM) AI Works
After the skin test panel is placed, staff simply captures an image using the device they already have. SkinSight(TM) AI instantly:
-- Detects positive reactions
-- Measures wheal and flare size
-- Identifies clinically meaningful responses
-- Documents structured results directly into the patient chart
No new steps. No new hardware. No retraining.
Building the Future of Data-Driven Allergy Care
SkinSight(TM) AI is the foundation for long-term innovation in allergy testing. Upcoming capabilities will include:
-- Longitudinal comparisons across visits
-- Trend analysis to monitor treatment impact
-- Medication-response insights for more tailored care
These enhancements will empower practices to move beyond subjective measurement and towards measurable, outcomes-based allergy care.
Supporting Practices Amid CPT 95004 Pressure
With reimbursement for CPT 95004 remaining flat, allergy practices must find ways to optimize accuracy and efficiency without increasing labour. SkinSight(TM) AI helps bridge this gap by:
-- Reducing manual workload
-- Standardizing documentation
-- Supporting outcomes reporting and transparency
A Platform Built for Modern Allergy, Immunotherapy, and Biologic Care
ModuleMD, ranked among America's fastest-growing companies on the Inc. 5000 and highly rated on G2, is more than an EHR vendor. They are a specialty-driven platform that runs Allergy/ Immunotherapy, and Biologics workflows directly within the EMR itself.
SkinSight(TM) AI is the latest example of ModuleMD's mission: building purpose-built tools that reduce clinical burden, standardize treatment, support precision therapy, and strengthen patient trust all inside one connected allergy platform. To know more on ModuleMD, visit www.modulemd.com
SkinSight(TM) Patent Pending*
(*Asterisk intentionally added to mark proprietary branding.)
Logo: https://mma.prnewswire.com/media/2637848/Module_MD_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/skinsight-ai-by-modulemd-smarter-skin-analysis-faster-clinical-decisions-302635235.html
SOURCE ModuleMD Healthcare Solutions Private Limited
|
|
|
|
|
 |
Energy Toolbase Launches Energy Storage Partnership with Sungrow to Support PowerStack 255CS and PowerTitan 2.0 | Jan 22, 2026
|
|
Fresco Raises EUR15m Series C to Power the Future of AI-Driven Cooking and the Connected Kitchen Ecosystem | Jan 22, 2026
|
|
No Assembly Required: Barrett Distribution Centers Powers Maxwood Furniture's West Coast DTC Expansion | Jan 22, 2026
|
|
MetaOptics to Showcase Five Breakthrough Metalens-Powered Products at CES 2026 | Jan 22, 2026
|
|
SCAILIUM Debuts "AI Production Layer" to Overcome GPU Starvation and Slash AI Energy Waste | Jan 22, 2026
|
|
RS now offers Phoenix Contact's pioneering new NearFi technology | Jan 22, 2026
|
|
Daikin Applied Invests $163M in Advanced R&D Test Lab to Bolster HVAC Innovation for Data Centers and Beyond | Jan 22, 2026
|
|
Einride and IonQ Partnership Uses Quantum Computing to Optimize the Logistics of Electric and Autonomous Freight | Jan 22, 2026
|
|
Hesai Recognized as the Only Lidar Company on Morgan Stanley's "Humanoid Tech 25" of Global Robotics Leaders | Jan 22, 2026
|
|
Lumana Surpasses 50,000 Cameras, Cementing Its Leadership in AI Video Surveillance | Jan 22, 2026
|
|
|
